Michael Thomas Henderson
Chief Executive Officer at Apogee Therapeutics · 28 reported transactions in 2 companies · latest trade Jul 8, 2026
Their trades
Sold | Jul 8, 2026 | |||
Sold | Jun 22, 2026 | |||
Sold | Jun 22, 2026 | Jun 22, 2026 close $100.32 → Oct 29, 2026 close $98.96. S&P 500 +3.8% over the same days. | ||
Sold | Jun 10, 2026 | |||
Sold | Jun 10, 2026 | |||
Sold | Jun 10, 2026 | |||
Sold | Jun 10, 2026 | |||
Sold | Jun 10, 2026 | |||
Sold | Jun 10, 2026 |
$2M
Jun 22, 2026 close $100.32 → Oct 29, 2026 close $98.96. S&P 500 +3.8% over the same days.